Position in FULC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,066,130
+$660,451 QoQ
Shares Held
139,000
+135.7% QoQ
Ownership
0.209%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 168 holders
Holding Since
Sep 2020
20 quarters on record
Voting authority
Sole 98.48920863309353.ToString("F0")%
Shared 0.ToString("F0")%
None 1.5107913669064748.ToString("F0")%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $5,509,413,147 across 314 Biotechnology names. FULC ranks #190 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,992,577 | $659,283,951 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
812,236 | $627,566,023 | |
| 3 | MRNA |
Moderna, Inc.
|
9,086,404 | $461,589,323 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
5,857,629 | $439,849,361 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
3,120,631 | $231,738,058 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
378,146 | $168,857,314 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,558,807 | $151,593,980 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
4,432,142 | $144,221,900 |
All Filings in FULC
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,066,130 | 139,000 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $405,679 | 58,965 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $432,789 | 150,274 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $796,847 | 169,542 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $971,421 | 272,107 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,160,065 | 509,688 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,654,114 | 175,224 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,766,826 | 261,752 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,495,826 | 562,123 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,906,957 | 577,866 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,851,958 | 649,810 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $968,378 | 133,019 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $1,052,338 | 214,763 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $399,685 | 16,900 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $9,216,313 | 520,990 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $17,843,925 | 632,539 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $163,603 | 15,611 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $164,672 | 13,979 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $323,746 | 27,647 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $91,195 | 11,500 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||